Literature DB >> 9556092

Prognosis of colorectal cancer varies in different high-risk conditions.

M Aarnio1, H Mustonen, J P Mecklin, H J Järvinen.   

Abstract

Variation in prognosis between different colorectal cancer (CRC) patient groups was studied by comparing the survival rates of patients belonging to three cancer predisposition groups with those with sporadic CRC. The high-risk groups included 43 members of hereditary nonpolyposis colorectal cancer (HNPCC) families, 25 patients with familial adenomatous polyposis (FAP) and 33 patients with underlying ulcerative colitis (UC). The control group included 122 consecutive sporadic CRC patients. Cumulative 5-year survival was highest in HNPCC (86%), which is significantly better than in sporadic colorectal cancer (59%, hazard ratio 0.41, P = 0.02). Cancer associated with UC had a 5-year survival rate of 39%, which is significantly less than in sporadic cancer (hazard ratio 1.83, P = 0.03). There was no significant difference in the survival between patients with FAP and patients with sporadic CRC (hazard ratio 1.27, P = 0.5). Exclusion of cases detected by screening examinations slightly reduced the survival rates; 85% for HNPCC, 53% for FAP and 28% for UC. However, the differences between the groups remained significant. The survival of patients with HNPCC was found to be better than that among other groups in this study, which probably relates to the specific tumourigenesis involving DNA mismatch repair dysfunction.

Entities:  

Mesh:

Year:  1998        PMID: 9556092     DOI: 10.3109/07853899808999387

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  16 in total

1.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

3.  Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.

Authors:  Bianca W Chang; Aryavarta M S Kumar; Shlomo A Koyfman; Matthew Kalady; Ian Lavery; May Abdel-Wahab
Journal:  Int J Colorectal Dis       Date:  2015-01-08       Impact factor: 2.571

4.  Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Authors:  Bernhard W Renz; Wolfgang E Thasler; Gerhard Preissler; Tobias Heide; Philippe N Khalil; Michael Mikhailov; Karl-Walter Jauch; Martin E Kreis; Markus Rentsch; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2013-03-09       Impact factor: 3.452

Review 5.  A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.

Authors:  Ian S Reynolds; Aobhlinn O'Toole; Joseph Deasy; Deborah A McNamara; John P Burke
Journal:  Int J Colorectal Dis       Date:  2017-01-11       Impact factor: 2.571

6.  Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Baochi Ou; Jingkun Zhao; Shaopei Guan; Aiguo Lu
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

7.  Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.

Authors:  Jordan Axelrad; Anuja Kriplani; Umut Ozbek; Noam Harpaz; Jean-Frederic Colombel; Steven Itzkowitz; Randall F Holcombe; Celina Ang
Journal:  Clin Colorectal Cancer       Date:  2016-09-20       Impact factor: 4.481

8.  Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania--initial results.

Authors:  Pavel Elsakov; Juozas Kurtinaitis
Journal:  Fam Cancer       Date:  2006-07-07       Impact factor: 2.375

9.  Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.

Authors:  Scott V Adams; Dennis J Ahnen; John A Baron; Peter T Campbell; Steven Gallinger; William M Grady; Loic LeMarchand; Noralane M Lindor; John D Potter; Polly A Newcomb
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 10.  Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent?

Authors:  A J Clark; R Barnetson; S M Farrington; M G Dunlop
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.